• Home
  • Pfizer-BioNTech

Decision on emergency use listing of Covaxin likely in 4-6 weeks, says WHO

Pfizer-BioNTech to seek authorisation for 3rd Covid shot: Statement

Product info on Moderna, Pfizer-BioNTech COVID vaccines warn of heart inflammation risk

Organ transplant recipients vulnerable to COVID-19 even after vaccination, says study

EU agrees potential 1.8 billion-dose purchase of Pfizer jab

Vaccine patent waiver sets dangerous precedent, says Big Pharma

Offered not-for-profit price for COVID vax; to supply through govt contracts in India: Pfizer

WHO clears COVID-19 vaccine for emergency use

US gives final nod to emergency use of Pfizer-BioNTech COVID-19 vaccine

Pfizer-BioNTech Covid-19 vaccine data hit by cyberattack; probe on

UK becomes first country to approve Pfizer-BioNtech COVID-19 vaccine

Latest Additions

Rajnath, Yediyurappa, Arjun Munda central observers for BJP MLAs’ meet to pick Gujarat CM

Atmosphere of terror in Karnataka’s Marathi-speaking areas: BJP ally in Lok Sabha

Serial producers demand removal of actor Aniruddha from S Narayan’s ‘Suryavamsha’

Kerala CM launches 27th IFFK by switching on arc light

23 first-time MLAs in 68-member Himachal assembly

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.